Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

European Journal of Internal Medicine

Volumn 26, Issue 7, 2015, Pages 545-553

  Groh, Matthieu ^a   Pagnoux, Christian ^b   Baldini, Chiara ^c   Bel, Elisabeth ^d   Bottero, Paolo ^e   Cottin, Vincent ^f   Dalhoff, Klaus ^g   Dunogué, Bertrand ^a   Gross, Wolfgang ^g   Holle, Julia ^g   Humbert, Marc ^h   Jayne, David ⁱ   Jennette, J Charles ^j   Lazor, Romain ^k   Mahr, Alfred ^l   Merkel, Peter A ^m   Mouthon, Luc ^a   Sinico, Renato Alberto ⁿ   Specks, Ulrich ^o   Vaglio, Augusto ^p   Wechsler, Michael E ^q   Cordier, Jean François ^f   Guillevin, Loïc ^a   more..

^a Université Paris Descartes ^*  (France)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e FATEBENEFRATELLI HOSPITAL   (Italy)

^f HOSPICES CIVILS DE LYON   (France)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h BICÊTRE HOSPITAL   (France)

ⁱ ADDENBROOKE S HOSPITAL   (United Kingdom)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l SAINT LOUIS HOSPITAL   (France)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ SAN CARLO BORROMEO HOSPITAL   (Italy)

^o MAYO CLINIC   (United States)

^p UNIVERSITY HOSPITAL OF PARMA   (Italy)

^q DEPARTMENT OF MEDICINE   (United States)

more..

Author keywords

Anti neutrophil cytoplasm antibody associated vasculitis; Asthma; Churg Strauss syndrome; Eosinophilia; Eosinophilic granulomatosis with polyangiitis; Recommendations

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; IMMUNOGLOBULIN; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

APPARENT LIFE THREATENING EVENT; ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL EVALUATION; CONSENSUS; CORTICOSTEROID THERAPY; DELPHI STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS; EUROPE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOGLOBULIN DEFICIENCY; IMMUNOLOGIST; IMMUNOTHERAPY; INTERNIST; LUNG EMBOLISM; MAINTENANCE THERAPY; NEPHROLOGIST; PATHOLOGIST; PATIENT MONITORING; PLASMAPHERESIS; PULMONOLOGIST; RECURRENT INFECTION; REMISSION; RHEUMATOLOGY; UNITED STATES; VENOUS THROMBOEMBOLISM; ADVISORY COMMITTEE; CHURG-STRAUSS SYNDROME; DISEASE MANAGEMENT; GRANULOMATOSIS WITH POLYANGIITIS;

ADVISORY COMMITTEES; CHURG-STRAUSS SYNDROME; CONSENSUS; DISEASE MANAGEMENT; EUROPE; GLUCOCORTICOIDS; GRANULOMATOSIS WITH POLYANGIITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RITUXIMAB; UNITED STATES;

EID: 84941599615     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.04.022     Document Type: Article

References (106)

1. J.C. Jennette, R.J. Falk, P.A. Bacon, N. Basu, M.C. Cid, F. Ferrario, and et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 1 2013 1 11
2. C. Mukhtyar, L. Guillevin, M.C. Cid, B. Dasgupta, K. de Groot, W. Gross, and et al. EULAR recommendations for the management of primary small and medium vessel vasculitis Ann Rheum Dis 68 3 2009 310 317
3. C. Comarmond, C. Pagnoux, M. Khellaf, J.F. Cordier, M. Hamidou, J.F. Viallard, and et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort Arthritis Rheum 65 1 2013 270 281
4. R.A. Sinico, L. Di Toma, U. Maggiore, P. Bottero, A. Radice, C. Tosoni, and et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 9 2005 2926 2935
5. R. Sablé-Fourtassou, P. Cohen, A. Mahr, C. Pagnoux, L. Mouthon, D. Jayne, and et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome Ann Intern Med 143 9 2005 632 638
6. B. Healy, S. Bibby, R. Steele, M. Weatherall, H. Nelson, and R. Beasley Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome J Allergy Clin Immunol 131 2 2013 571 576
7. K.A. Keogh, and U. Specks Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists Am J Med 115 4 2003 284 290
8. A.D. Klion, B.S. Bochner, G.J. Gleich, T.B. Nutman, M.E. Rothenberg, H.U. Simon, and et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report J Allergy Clin Immunol 117 6 2006 1292 1302
9. J.C. Andrews, H.J. Schunemann, A.D. Oxman, K. Pottie, J.J. Meerpohl, P.A. Coello, and et al. GRADE guidelines: 15. Going from evidence to recommendation - determinants of a recommendation's direction and strength J Clin Epidemiol 66 7 2013 726 735
10. G. Haugeberg, R. Bie, A. Bendvold, A.S. Larsen, and V. Johnsen Primary vasculitis in a Norwegian community hospital: a retrospective study Clin Rheumatol 17 5 1998 364 368
11. A. Mahr, L. Guillevin, M. Poissonnet, and S. Aymé Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate Arthritis Rheum 51 1 2004 92 99
12. A.J. Mohammad, L.T. Jacobsson, A.D. Mahr, G. Sturfelt, and M. Segelmark Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden Rheumatology (Oxford) 46 8 2007 1329 1337
13. R.A. Watts, S. Lane, and D.G. Scott What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19 2 2005 191 207
14. K. Herlyn, B. Hellmich, W.L. Gross, and E. Reinhold-Keller Stable incidence of systemic vasculitides in Schleswig-Holstein, Germany Dtsch Arztebl Int 105 19 2008 355 361
15. R.M. Martin, L.V. Wilton, and R.D. Mann Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies Pharmacoepidemiol Drug Saf 8 3 1999 179 189
16. L.R. Harrold, S.E. Andrade, A.S. Go, A.S. Buist, M. Eisner, W.M. Vollmer, and et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective J Rheumatol 32 6 2005 1076 1080
17. F. Moosig, J.P. Bremer, B. Hellmich, J.U. Holle, K. Holl-Ulrich, M. Laudien, and et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients Ann Rheum Dis 72 6 2013 1011 1017
18. F. Roufosse, and P.F. Weller Practical approach to the patient with hypereosinophilia J Allergy Clin Immunol 126 1 2010 39 44
19. P. Valent, A.D. Klion, H.P. Horny, F. Roufosse, J. Gotlib, P.F. Weller, and et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes J Allergy Clin Immunol 130 3 2012 607 612
20. M.R. Taylor, C.T. Keane, P. O'Connor, E. Mulvihill, and C. Holland The expanded spectrum of toxocaral disease Lancet 1 8587 1988 692 695
21. A.A. Siddiqui, and S.L. Berk Diagnosis of Strongyloides stercoralis infection Clin Infect Dis 33 7 2001 1040 1047
22. R. Agarwal Allergic bronchopulmonary aspergillosis Chest 135 3 2009 805 826
23. E. Cogan, L. Schandene, A. Crusiaux, P. Cochaux, T. Velu, and M. Goldman Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome N Engl J Med 330 8 1994 535 538
24. A. de Lavareille, F. Roufosse, P. Schmid-Grendelmeier, A.S. Roumier, L. Schandene, E. Cogan, and et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome J Allergy Clin Immunol 110 3 2002 476 479
25. P.U. Ogbogu, B.S. Bochner, J.H. Butterfield, G.J. Gleich, J. Huss-Marp, J.E. Kahn, and et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy J Allergy Clin Immunol 124 6 2009 1319 1325
26. F. Legrand, A. Renneville, E. Macintyre, S. Mastrilli, F. Ackermann, J.M. Cayuela, and et al. The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases Medicine (Baltimore) Aug 26 2013 [Epub ahead of print]
27. E. Marchand, M. Reynaud-Gaubert, D. Lauque, J. Durieu, A.B. Tonnel, and J.F. Cordier Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Études et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P) Medicine (Baltimore) 77 5 1998 299 312
28. J.F. Cordier, V. Cottin, L. Guillevin, E. Bel, P. Bottero, K. Dalhoff, and et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) Presse Med 42 4 Pt 2 2013 507 510
29. H.K. Choi, S. Liu, P.A. Merkel, G.A. Colditz, and J.L. Niles Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies J Rheumatol 28 7 2001 1584 1590
30. M. Groh, G. Masciocco, E. Kirchner, A. Kristen, C. Pellegrini, S. Varnous, and et al. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) J Heart Lung Transplant 33 8 2014 842 850
31. M. Samson, X. Puéchal, H. Devilliers, C. Ribi, P. Cohen, M. Stern, and et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials J Autoimmun 43 2013 60 69
32. P.C. Grayson, P.A. Monach, C. Pagnoux, D. Cuthbertson, S. Carette, G.S. Hoffman, and et al. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis Rheumatology Nov 17 2014 [Epub ahead of print]
33. P. Guilpain, J.-F. Auclair, M.C. Tamby, A. Servettaz, A. Mahr, B. Weill, and et al. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome Ann N Y Acad Sci 1107 2007 392 399
34. S. Hurst, C. Chizzolini, J.M. Dayer, J. Olivieri, and P. Roux-Lombard Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis Clin Exp Rheumatol 18 6 2000 784 785
35. K. Herrmann, W.L. Gross, and F. Moosig Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome Clin Exp Rheumatol 30 1 Suppl. 70 2012 S62 S65
36. T. Dallos, G.R. Heiland, J. Strehl, T. Karonitsch, W.L. Gross, F. Moosig, and et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome Arthritis Rheum 62 11 2010 3496 3503
37. A. Vaglio, J.D. Strehl, B. Manger, F. Maritati, F. Alberici, C. Beyer, and et al. IgG4 immune response in Churg-Strauss syndrome Ann Rheum Dis 71 3 2012 390 393
38. J. Zwerina, C. Bach, D. Martorana, M. Jatzwauk, G. Hegasy, F. Moosig, and et al. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study Rheumatology (Oxford) 50 10 2011 1823 1827
39. K. Polzer, T. Karonitsch, T. Neumann, G. Eger, C. Haberler, A. Soleiman, and et al. Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity Rheumatology (Oxford) 47 6 2008 804 808
40. National Asthma Education and Prevention Program Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 2007 S94 S138
41. L. Guillevin, C. Pagnoux, R. Seror, A. Mahr, L. Mouthon, and P. Le Toumelin The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort Medicine (Baltimore) 90 1 2011 19 27
42. J. Marmursztejn, L. Guillevin, R. Trebossen, P. Cohen, P. Guilpain, C. Pagnoux, and et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients Rheumatology (Oxford) 52 4 2013 642 650
43. J. Marmursztejn, P. Cohen, D. Duboc, C. Pagnoux, L. Mouthon, P. Guilpain, and et al. Cardiac magnetic resonance imaging in Churg-Strauss syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients Clin Exp Rheumatol 28 1 Suppl. 57 2010 8 13
44. J. Marmursztejn, O. Vignaux, P. Cohen, P. Guilpain, C. Pagnoux, H. Gouya, and et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients Clin Exp Rheumatol 27 1 Suppl. 52 2009 S70 S76
45. T. Neumann, B. Manger, M. Schmid, C. Kroegel, A. Hansch, W.A. Kaiser, and et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis Medicine (Baltimore) 88 4 2009 236 243
46. R.M. Dennert, P. van Paassen, S. Schalla, T. Kuznetsova, B.S. Alzand, J.A. Staessen, and et al. Cardiac involvement in Churg-Strauss syndrome Arthritis Rheum 62 2 2010 627 634
47. C. Pagnoux, A. Mahr, P. Cohen, and L. Guillevin Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis Medicine (Baltimore) 84 2 2005 115 128
48. K. de Groot, D. Adu, and C.O. Savage The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review Nephrol Dial Transplant 16 10 2001 2018 2027
49. L. Harper, M.D. Morgan, M. Walsh, P. Hoglund, K. Westman, O. Flossmann, and et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up Ann Rheum Dis 71 6 2012 955 960
50. M. Gayraud, L. Guillevin, P. Le Toumelin, P. Cohen, F. Lhote, P. Casassus, and et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients Arthritis Rheum 44 3 2001 666 675
51. C. Pagnoux, T. Quéméneur, J. Ninet, E. Perrodeau, E. Diot, X. Kyndt, and et al. Treatment of systemic necrotizing vasculitides in patients ≥ 65 years old: results of the multicenter randomized CORTAGE trial (Abstract) Presse Med 42 2013 679 680
52. E.C. Somers, W. Marder, G.M. Christman, V. Ognenovski, and W.J. McCune Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus Arthritis Rheum 52 9 2005 2761 2767
53. J.B. Chung, K. Armstrong, J.S. Schwartz, and D. Albert Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy Arthritis Rheum 43 8 2000 1841 1848
54. F.P. Ognibene, J.H. Shelhamer, G.S. Hoffman, G.S. Kerr, D. Reda, A.S. Fauci, and et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis Am J Respir Crit Care Med 151 3 Pt 1 1995 795 799
55. P. Cohen, C. Pagnoux, A. Mahr, J.P. Arène, L. Mouthon, V. Le Guern, and et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients Arthritis Rheum 57 4 2007 686 693
56. D. Jayne, N. Rasmussen, K. Andrassy, P. Bacon, J.W. Tervaert, J. Dadoniene, and et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 1 2003 36 44
57. T.F. Hiemstra, M. Walsh, A. Mahr, C.O. Savage, K. de Groot, L. Harper, and et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial JAMA 304 21 2010 2381 2388
58. C. Pagnoux, A. Mahr, M.A. Hamidou, J.J. Boffa, M. Ruivard, J.P. Ducroix, and et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis N Engl J Med 359 26 2008 2790 2803
59. L. Guillevin, F. Lhote, P. Cohen, B. Jarrousse, O. Lortholary, T. Généreau, and et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients Arthritis Rheum 38 11 1995 1638 1645
60. L. Guillevin, O. Fain, F. Lhote, B. Jarrousse, D. Lê Thi Huong, A. Bussel, and et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients Arthritis Rheum 35 2 1992 208 215
61. P.J. Klemmer, W. Chalermskulrat, M.S. Reif, S.L. Hogan, D.C. Henke, and R.J. Falk Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis Am J Kidney Dis 42 6 2003 1149 1153
62. D.R. Jayne, G. Gaskin, N. Rasmussen, D. Abramowicz, F. Ferrario, L. Guillevin, and et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 7 2007 2180 2188
63. M. Walsh, A. Casian, O. Flossmann, K. Westman, P. Hoglund, C. Pusey, and et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear Kidney Int 84 2 2013 397 402
64. M. Walsh, P.A. Merkel, C.A. Peh, W. Szpirt, L. Guillevin, C.D. Pusey, and et al. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial Trials 14 2013 73
65. J.H. Stone, P.A. Merkel, R. Spiera, P. Seo, C.A. Langford, G.S. Hoffman, and et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 3 2010 221 232
66. R.B. Jones, J.W. Tervaert, T. Hauser, R. Luqmani, M.D. Morgan, C.A. Peh, and et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 3 2010 211 220
67. L. Guillevin, C. Pagnoux, A. Karras, C. Khouatra, O. Aumaître, P. Cohen, and et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis N Engl J Med 371 19 2014 1771 1780
68. M. Koukoulaki, K.G. Smith, and D.R. Jayne Rituximab in Churg-Strauss syndrome Ann Rheum Dis 65 4 2006 557 559
69. J. Saech, K. Owczarzyk, S. Rosgen, H. Petereit, M. Hallek, and A. Rubbert-Roth Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement Ann Rheum Dis 69 6 2010 1254 1255
70. R. Cartin-Ceba, J. Golbin, K. Keogh, T. Peikert, M. Sánchez-Menéndez, S. Ytterberg, and et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center Arthritis Rheum 64 2012 3770 3778
71. J. Thiel, F. Hässler, U. Salzer, R.E. Voll, and N. Venhoff Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) Arthritis Res Ther 15 5 2013 R133
72. A.J. Mohammad, A. Hot, F. Arndt, F. Moosig, M.J. Guerry, N. Amudala, and et al. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) Ann Rheum Dis Dec 2 2014 [Epub ahead of print]
73. M.A. Bouldouyre, P. Cohen, and L. Guillevin Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome Ann Rheum Dis 68 4 2009 606
74. R.J. Pepper, M.A. Fabre, C. Pavesio, G. Gaskin, R.B. Jones, D. Jayne, and et al. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production Rheumatology (Oxford) 47 7 2008 1104 1105
75. A. Armentia, A. Fernandez, P. Sanchez, R. de la Fuente, E. Sanchis, J. Mendez, and et al. Asthma and vasculitis. Response to intravenous immunoglobulins Allergol Immunopathol (Madr) 21 2 1993 47 52
76. Y. Levy, J. George, F. Fabbrizzi, P. Rotman, Y. Paz, and Y. Shoenfeld Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins South Med J 92 4 1999 412 414
77. N. Tsurikisawa, M. Taniguchi, H. Saito, H. Himeno, A. Ishibashi, S. Suzuki, and et al. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin Ann Allergy Asthma Immunol 92 1 2004 80 87
78. S.A. Rutberg, D.E. Ward, and B.J. Roth Churg-Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin J Clin Rheumatol 8 3 2002 151 156
79. M.G. Danieli, M. Cappelli, G. Malcangi, F. Logullo, A. Salvi, and G. Danieli Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome Ann Rheum Dis 63 12 2004 1649 1654
80. E. Tatsis, A. Schnabel, and W.L. Gross Interferon-alpha treatment of four patients with the Churg-Strauss syndrome Ann Intern Med 129 5 1998 370 374
81. C. Metzler, E. Csernok, W.L. Gross, and B. Hellmich Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study Clin Exp Rheumatol 28 1 Suppl. 57 2010 24 30
82. M.E. Wechsler, and J.M. Drazen Zafirlukast and Churg-Strauss syndrome Chest 116 1 1999 266 267
83. M.E. Wechsler, D. Finn, D. Gunawardena, R. Westlake, A. Barker, S.P. Haranath, and et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma Chest 117 3 2000 708 713
84. L.R. Harrold, M.K. Patterson, S.E. Andrade, T. Dube, A.S. Go, A.S. Buist, and et al. Asthma drug use and the development of Churg-Strauss syndrome (CSS) Pharmacoepidemiol Drug Saf 16 6 2007 620 626
85. N. Nathani, M.A. Little, H. Kunst, D. Wilson, and D.R. Thickett Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective Thorax 63 10 2008 883 888
86. T. Hauser, A. Mahr, C. Metzler, J. Coste, R. Sommerstein, W.L. Gross, and et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study Thorax 63 8 2008 677 682
87. M. Vanoli, D. Gambini, and R. Scorza A case of Churg-Strauss vasculitis after hepatitis B vaccination Ann Rheum Dis 57 4 1998 256 257
88. L. Guillevin, T. Guittard, O. Blétry, P. Godeau, and P. Rosenthal Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases Lung 165 3 1987 165 172
89. M.R. Masjedi, S.F. Tafti, A. Cheraghvandi, N. Fayazi, F. Talischi, and B. Mokri Churg-Strauss syndrome following cessation of allergic desensitization vaccination: a case report J Med Case Rep 4 2010 188
90. D.C. Wraith, M. Goldman, and P.H. Lambert Vaccination and autoimmune disease: what is the evidence? Lancet 362 9396 2003 1659 1666
91. A. Bourgarit, P. Le Toumelin, C. Pagnoux, P. Cohen, A. Mahr, V. Le Guern, and et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients Medicine (Baltimore) 84 5 2005 323 330
92. A. Kostianovsky, P. Charles, J.F. Alves, M. Goulet, C. Pagnoux, V. Le Guern, and et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients Clin Exp Rheumatol 30 1 Suppl. 70 2012 S83 S89
93. A. Kostianovsky, P. Charles, J. Alves, M. Goulet, C. Pagnoux, V. Le Guern, and et al. Seasonal and pandemic 2009 H1N1 influenza vaccine for patients with autoimmune diseases, immunogenicity and safety; a monocentric prospective trial on 199 patients Clin Exp Rheumatol 30 2012 S83 S89
94. L.G. Rubin, M.J. Levin, P. Ljungman, E.G. Davies, R. Avery, M. Tomblyn, and et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host Clin Infect Dis 58 3 2014 e44 e100
95. K. Herlyn, W.L. Gross, and E. Reinhold-Keller Longitudinale Effekte des strukturierten Patientenschulungsprogramms fur Vaskulitispatienten Z Rheumatol 67 3 2008 206 210
96. J.K. Richardson, D. Sandman, and S. Vela A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy Arch Phys Med Rehabil 82 2 2001 205 209
97. J.L. Ruhland, and R.K. Shields The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies Phys Ther 77 10 1997 1026 1039
98. K.F. Chung, S.E. Wenzel, J.L. Brozek, A. Bush, M. Castro, P.J. Sterk, and et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 2 2014 343 373
99. Y. Allenbach, R. Seror, C. Pagnoux, L. Teixeira, P. Guilpain, and L. Guillevin High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients Ann Rheum Dis 68 4 2009 564 567
100. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, and et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 18 2008 2276 2315
101. P.U. Ogbogu, D.R. Rosing, and M.K. Horne III Cardiovascular manifestations of hypereosinophilic syndromes Immunol Allergy Clin North Am 27 3 2007 457 475
102. E.H. Bel, S.E. Wenzel, P.J. Thompson, C.M. Prazma, O.N. Keene, S.W. Yancey, and et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma N Engl J Med 371 13 2014 1189 1197
103. H.G. Ortega, M.C. Liu, I.D. Pavord, G.G. Brusselle, J.M. FitzGerald, A. Chetta, and et al. Mepolizumab treatment in patients with severe eosinophilic asthma N Engl J Med 371 13 2014 1198 1207
104. J.E. Kahn, C. Grandpeix-Guyodo, I. Marroun, E. Catherinot, F. Mellot, F. Roufosse, and et al. Sustained response to mepolizumab in refractory Churg-Strauss syndrome J Allergy Clin Immunol 125 1 2010 267 270
105. S. Kim, G. Marigowda, E. Oren, E. Israel, and M.E. Wechsler Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome J Allergy Clin Immunol 125 6 2010 1336 1343
106. F. Moosig, W.L. Gross, K. Herrmann, J.P. Bremer, and B. Hellmich Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome Ann Intern Med 155 5 2011 341 343